Home » First Subject Dosed in Phase Ib Trial of Oxycodone Patch
First Subject Dosed in Phase Ib Trial of Oxycodone Patch
Phosphagenics Limited Wednesday announced the initiation of a Phase 1B clinical
trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.
Fox Business
Fox Business
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May